Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Loeys-Dietz Syndrome | 2 | 2025 | 40 | 1.050 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2025 | 47 | 0.990 |
Why?
|
| Williams Syndrome | 1 | 2024 | 41 | 0.880 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2024 | 21 | 0.880 |
Why?
|
| Transition to Adult Care | 1 | 2021 | 118 | 0.620 |
Why?
|
| Premature Birth | 1 | 2022 | 388 | 0.580 |
Why?
|
| Registries | 1 | 2024 | 1434 | 0.570 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 1830 | 0.500 |
Why?
|
| Marfan Syndrome | 2 | 2025 | 143 | 0.410 |
Why?
|
| Collagen Type III | 2 | 2025 | 22 | 0.260 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2024 | 459 | 0.250 |
Why?
|
| Folic Acid | 2 | 2024 | 293 | 0.230 |
Why?
|
| Infant Mortality | 1 | 2024 | 176 | 0.210 |
Why?
|
| Arteries | 1 | 2023 | 218 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 193 | 0.190 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2022 | 72 | 0.190 |
Why?
|
| Congenital Abnormalities | 1 | 2024 | 257 | 0.180 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 109 | 0.180 |
Why?
|
| Ataxia | 1 | 2022 | 170 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 224 | 0.180 |
Why?
|
| Child | 8 | 2024 | 24607 | 0.170 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8272 | 0.170 |
Why?
|
| Aorta | 1 | 2024 | 545 | 0.170 |
Why?
|
| Humans | 14 | 2025 | 125466 | 0.170 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 192 | 0.170 |
Why?
|
| Male | 9 | 2025 | 61637 | 0.160 |
Why?
|
| Neural Tube Defects | 1 | 2023 | 356 | 0.160 |
Why?
|
| Personal Autonomy | 1 | 2021 | 202 | 0.160 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 640 | 0.160 |
Why?
|
| Motivation | 1 | 2021 | 319 | 0.150 |
Why?
|
| Echocardiography | 1 | 2024 | 1066 | 0.150 |
Why?
|
| Female | 9 | 2025 | 66904 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 2083 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 392 | 0.150 |
Why?
|
| Caregivers | 1 | 2023 | 578 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2022 | 356 | 0.140 |
Why?
|
| Seizures | 1 | 2022 | 871 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2024 | 1016 | 0.140 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2025 | 662 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 500 | 0.140 |
Why?
|
| Genotype | 1 | 2022 | 2569 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3433 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2025 | 16362 | 0.130 |
Why?
|
| Texas | 1 | 2024 | 3583 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 617 | 0.120 |
Why?
|
| Adolescent | 5 | 2024 | 19448 | 0.110 |
Why?
|
| Infant | 3 | 2024 | 12601 | 0.110 |
Why?
|
| Quality of Life | 1 | 2023 | 1949 | 0.110 |
Why?
|
| Pregnancy | 2 | 2022 | 7225 | 0.100 |
Why?
|
| Adult | 4 | 2025 | 29642 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2022 | 224 | 0.090 |
Why?
|
| Middle Aged | 3 | 2025 | 26833 | 0.080 |
Why?
|
| Mutation | 1 | 2022 | 5903 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2024 | 14143 | 0.070 |
Why?
|
| Young Adult | 1 | 2021 | 9086 | 0.070 |
Why?
|
| Fibrillin-1 | 1 | 2025 | 59 | 0.060 |
Why?
|
| Adipokines | 1 | 2025 | 60 | 0.060 |
Why?
|
| Mitral Valve Prolapse | 1 | 2024 | 28 | 0.060 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2024 | 61 | 0.060 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 160 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2024 | 252 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 164 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 55 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2022 | 106 | 0.050 |
Why?
|
| Propranolol | 1 | 2022 | 128 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 123 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2023 | 389 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 348 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 4843 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 6174 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 10301 | 0.020 |
Why?
|
| United States | 1 | 2023 | 10926 | 0.020 |
Why?
|